References
- Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol. 2015;69:71–92.
- Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. 2011;10:112–22.
- Singh S, Fatima Z, Hameed S. Predisposing factors endorsing Candida infections. Infez Med. 2015;23(3):211–23.
- Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int. 2013;2013:204237.
- Bielsa I, Miro JM, Herrero C, Martin E, Latorre X, Mascaro JM. Systemic candidiasis in heroin abusers. Cutaneous findings. Int J Dermatol. 1987;26:314–9.
- Leclech C, Cimon B, Chennebault JM, Verret JL. [Pustular candidiasis in heroin addicts]. Ann Dermatol Venereol. 1997;124:157–8.
- Leclerc G, Weber M, Contet-Audonneau N, Beurey J. Candida folliculitis in heroin addicts. Int J Dermatol. 1986;25:100–2.
- Feuilhade de Chauvin M, Cosnes A, Benkhraba F, Touraine R. [Folliculitis of the scalp and beard caused by Candida albicans. Septicemic localization in a non drug-addicted patient]. Ann Dermatol Venereol. 1988;115:1162–4.
- Ng KP, Kuan CS, Kaur H, Na SL, Atiya N, Velayuthan RD. Candida species epidemiology 2000-2013: a laboratory-based report. Trop Med Int Health. 2015;20:1447–53.
- Katoh T. [Guidelines for diagnosis and treatment of mucocutaneous candidiasis]. Nihon Ishinkin Gakkai Zasshi. 2009;50:207–12.